Company Information
USD
4.19
- (0.8%)
NASDAQ:RXRX, RECURSION PHARMACEUTICALS, INC.
Industry: Biotechnology
End of Day: 7 May 2025 GMT-4
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Address
41 S Rio Grande Street
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Matthew Kinn
Other Executive Officer
Mr. Ramon Martin Chavez, PhD
Chairman of the Board/Director
Dr. Robert M. Hershberg, M.D.,PhD
Director
Dr. David J. Mauro, M.D.
Chief Medical Officer
Ms. Terry-Ann Burrell
Director
Mr. Dean Y. Li
Co-Founder/Director
Dr. Christopher Gibson, PhD
CEO/Co-Founder/Director
Dr. Michael Secora, PhD
CFO/Chief Accounting Officer
Mr. Zachary Bogue, J.D.
Director
Dr. Blake Borgeson, PhD
Director
Mr. Zavain Dar, PhD
Director
Ms. Tina Marriott Larson
COO/President
Ownership
Institution Holdings
Baillie Gifford & Co
24,820,850 (11.498%)
Baillie Gifford & Co Limited.
24,179,504 (11.201%)
ARK Investment Management LLC
20,654,287 (9.568%)
Vanguard Group Inc
15,665,210 (7.257%)
BlackRock Inc
12,393,872 (5.741%)
State Street Corporation
12,151,646 (5.629%)
FMR Inc
10,897,287 (5.048%)
Fidelity Management & Research Company LLC
9,646,229 (4.468%)
SSGA Funds Management Inc
9,638,191 (4.465%)
Nikko Asset Management Americas Inc
9,203,780 (4.264%)
Individual Holdings
Dr. Blake Borgeson, PhD
7,292,863 (3.501%)
Dr. Michael Secora, PhD
1,179,179 (0.566%)
Dr. Christopher Gibson, PhD
1,104,919 (0.531%)
Ms. Tina Marriott Larson
639,982 (0.307%)
Dr. David J. Mauro, M.D.
244,629 (0.117%)
Ms. Terry-Ann Burrell
54,847 (0.028%)
Mr. Ramon Martin Chavez, PhD
58,077 (0.028%)
Mr. Zavain Dar, PhD
55,216 (0.027%)
Dr. Robert M. Hershberg, M.D.,PhD
38,619 (0.021%)
Mr. Zachary Bogue, J.D.
9,378 (0.005%)
Funds Holdings
Scottish Mortgage Inv Tr
15,996,648 (7.410%)
ARK Innovation ETF
13,446,682 (6.229%)
SPDR® S&P Biotech ETF
9,495,069 (4.398%)
ARK Genomic Revolution
9,364,576 (4.338%)
ARK Genomic Revolution ETF
8,961,801 (4.151%)
Vanguard Total Stock Market Index Fund
5,169,457 (2.395%)
Vanguard US Total Market Shares ETF
5,169,457 (2.395%)
Nikko AM ARK Disruptive Innovation Fund
5,076,339 (2.352%)
Vanguard Small Cap Index
4,255,017 (1.971%)
Nikko AM ARK Positive Change Innovt Fd
3,875,434 (1.795%)
Make Smart Investment Choices